457 related articles for article (PubMed ID: 32506804)
21. Tumor infiltrating lymphocytes and PD-L1 expression in brain metastases of small cell lung cancer (SCLC).
Berghoff AS; Ricken G; Wilhelm D; Rajky O; Widhalm G; Dieckmann K; Birner P; Bartsch R; Preusser M
J Neurooncol; 2016 Oct; 130(1):19-29. PubMed ID: 27436101
[TBL] [Abstract][Full Text] [Related]
22. Expression of New York esophageal squamous cell carcinoma 1 and its association with Foxp3 and indoleamine-2,3-dioxygenase in microenvironment of nonsmall cell lung cancer.
Wang H; Xia Y; Yu J; Guan H; Wu Z; Ban D; Wang M
HLA; 2019 Jul; 94(1):39-48. PubMed ID: 30953385
[TBL] [Abstract][Full Text] [Related]
23. Indoleamine 2,3-Dioxygenase-1 Expression in Adrenocortical Carcinoma.
Tierney JF; Vogle A; Finnerty B; Zarnegar R; Ghai R; Gattuso P; Fahey TJ; Keutgen XM
J Surg Res; 2020 Dec; 256():90-95. PubMed ID: 32683062
[TBL] [Abstract][Full Text] [Related]
24. Human leukocyte antigen class II-based immune risk model for recurrence evaluation in stage I-III small cell lung cancer.
Chen P; Zhao L; Wang H; Zhang L; Zhang W; Zhu J; Yu J; Zhao S; Li W; Sun C; Wu C; He Y; Zhou C
J Immunother Cancer; 2021 Aug; 9(8):. PubMed ID: 34362829
[TBL] [Abstract][Full Text] [Related]
25. Analysis of the immune microenvironment in resected non-small cell lung cancer: the prognostic value of different T lymphocyte markers.
Usó M; Jantus-Lewintre E; Bremnes RM; Calabuig S; Blasco A; Pastor E; Borreda I; Molina-Pinelo S; Paz-Ares L; Guijarro R; Martorell M; Forteza J; Camps C; Sirera R
Oncotarget; 2016 Aug; 7(33):52849-52861. PubMed ID: 27463005
[TBL] [Abstract][Full Text] [Related]
26. Immuno-profiling and cellular spatial analysis using five immune oncology multiplex immunofluorescence panels for paraffin tumor tissue.
Parra ER; Ferrufino-Schmidt MC; Tamegnon A; Zhang J; Solis L; Jiang M; Ibarguen H; Haymaker C; Lee JJ; Bernatchez C; Wistuba II
Sci Rep; 2021 Apr; 11(1):8511. PubMed ID: 33875760
[TBL] [Abstract][Full Text] [Related]
27. Expression of HLA class I/II antigens and T cell immune response in human neuroendocrine tumors of the pancreas.
Ryschich E; Autschbach F; Eisold S; Klar E; Buchler MW; Schmidt J
Tissue Antigens; 2003 Jul; 62(1):48-54. PubMed ID: 12859594
[TBL] [Abstract][Full Text] [Related]
28. Metastatic spread in patients with non-small cell lung cancer is associated with a reduced density of tumor-infiltrating T cells.
Müller P; Rothschild SI; Arnold W; Hirschmann P; Horvath L; Bubendorf L; Savic S; Zippelius A
Cancer Immunol Immunother; 2016 Jan; 65(1):1-11. PubMed ID: 26541588
[TBL] [Abstract][Full Text] [Related]
29. Independent value of fascin immunoreactivity for predicting lymph node metastases in typical and atypical pulmonary carcinoids.
Pelosi G; Pasini F; Fraggetta F; Pastorino U; Iannucci A; Maisonneuve P; Arrigoni G; De Manzoni G; Bresaola E; Viale G
Lung Cancer; 2003 Nov; 42(2):203-13. PubMed ID: 14568688
[TBL] [Abstract][Full Text] [Related]
30. The Expression Pattern and Clinical Significance of the Immune Checkpoint Regulator VISTA in Human Breast Cancer.
Xie X; Zhang J; Shi Z; Liu W; Hu X; Qie C; Chen W; Wang Y; Wang L; Jiang J; Liu J
Front Immunol; 2020; 11():563044. PubMed ID: 33250890
[TBL] [Abstract][Full Text] [Related]
31. Ferroptosis response segregates small cell lung cancer (SCLC) neuroendocrine subtypes.
Bebber CM; Thomas ES; Stroh J; Chen Z; Androulidaki A; Schmitt A; Höhne MN; Stüker L; de Pádua Alves C; Khonsari A; Dammert MA; Parmaksiz F; Tumbrink HL; Beleggia F; Sos ML; Riemer J; George J; Brodesser S; Thomas RK; Reinhardt HC; von Karstedt S
Nat Commun; 2021 Apr; 12(1):2048. PubMed ID: 33824345
[TBL] [Abstract][Full Text] [Related]
32. Comprehensive Bioinformatics Analysis Identifies Tumor Microenvironment and Immune-related Genes in Small Cell Lung Cancer.
Song Y; Sun Y; Sun T; Tang R
Comb Chem High Throughput Screen; 2020; 23(5):381-391. PubMed ID: 32264809
[TBL] [Abstract][Full Text] [Related]
33. Prognostic Implications of the Immune Tumor Microenvironment in Patients With Pancreatic and Gastrointestinal Neuroendocrine Tumors.
Baretti M; Zhu Q; Zahurak M; Bhaijee F; Xu H; Engle EL; Kotte A; Pawlik TM; Anders RA; De Jesus-Acosta A
Pancreas; 2021 May-Jun 01; 50(5):719-726. PubMed ID: 34016898
[TBL] [Abstract][Full Text] [Related]
34. Analysis of p53, K-ras-2, and C-raf-1 in pulmonary neuroendocrine tumors. Correlation with histological subtype and clinical outcome.
Przygodzki RM; Finkelstein SD; Langer JC; Swalsky PA; Fishback N; Bakker A; Guinee DG; Koss M; Travis WD
Am J Pathol; 1996 May; 148(5):1531-41. PubMed ID: 8623922
[TBL] [Abstract][Full Text] [Related]
35. Lung Adenocarcinoma and Squamous Cell Carcinoma Gene Expression Subtypes Demonstrate Significant Differences in Tumor Immune Landscape.
Faruki H; Mayhew GM; Serody JS; Hayes DN; Perou CM; Lai-Goldman M
J Thorac Oncol; 2017 Jun; 12(6):943-953. PubMed ID: 28341226
[TBL] [Abstract][Full Text] [Related]
36. Single-cell transcriptomic profiling reveals the tumor heterogeneity of small-cell lung cancer.
Tian Y; Li Q; Yang Z; Zhang S; Xu J; Wang Z; Bai H; Duan J; Zheng B; Li W; Cui Y; Wang X; Wan R; Fei K; Zhong J; Gao S; He J; Gay CM; Zhang J; Wang J; Tang F
Signal Transduct Target Ther; 2022 Oct; 7(1):346. PubMed ID: 36195615
[TBL] [Abstract][Full Text] [Related]
37. Clinicopathological features and prognostic implications of ASCL1 expression in surgically resected small cell lung cancer.
Wei J; Liu L; Guo Y; Zhang J; Wang X; Dong J; Xing P; Ying J; Yang L; Li J
Thorac Cancer; 2021 Jan; 12(1):40-47. PubMed ID: 33191657
[TBL] [Abstract][Full Text] [Related]
38. Comparative expression analysis of immune-related markers in surgically resected lung neuroendocrine neoplasms.
Ferencz B; Megyesfalvi Z; Csende K; Fillinger J; Poór V; Lantos A; Pipek O; Sólyom-Tisza A; Rényi-Vámos F; Schelch K; Lang C; Schwendenwein A; Boettiger K; László V; Hoetzenecker K; Döme B; Berta J
Lung Cancer; 2023 Jul; 181():107263. PubMed ID: 37270937
[TBL] [Abstract][Full Text] [Related]
39. Comparison of four DLL3 antibodies performance in high grade neuroendocrine lung tumor samples and cell cultures.
Brcic L; Kuchler C; Eidenhammer S; Pabst D; Quehenberger F; Gazdar AF; Popper H
Diagn Pathol; 2019 May; 14(1):47. PubMed ID: 31109352
[TBL] [Abstract][Full Text] [Related]
40. Expression of programmed cell death protein 1 (PD-1) and indoleamine 2,3-dioxygenase (IDO) in the tumor microenvironment and in tumor-draining lymph nodes of breast cancer.
Ye Q; Wang C; Xian J; Zhang M; Cao Y; Cao Y
Hum Pathol; 2018 May; 75():81-90. PubMed ID: 29447919
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]